Study of Shunt Flow Sensor Accuracy in Extra-ventricular Drains.

Sponsor
Transonic Systems Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT01108965
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (NIH)
16
1
21
0.8

Study Details

Study Description

Brief Summary

The study hypothesis is that an ultrasonic flow sensor can accurately measure flow in hydrocephalic shunts.

The ultrasonic sensor will measure cerebrospinal fluid drainage in hydrocephalus patients with external ventriculostomies and extra-ventricular drainage systems. The sensor measurements will be compared with the volume of fluid collected by the drainage bag.

After a 24-hour measurement period, the doctor will change the drainage bag position to simulate the patient sitting up and leaning back, to see if this temporarily stops flow through the drainage line.

This data will show whether the sensor accurately measures typical drainage flows seen in hydrocephalus patients. This research will help develop an implantable flow monitor for pediatric hydrocephalus patients.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    16 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    A Flow Monitor for Pediatric Hydrocephalic Shunts
    Study Start Date :
    Aug 1, 2010
    Actual Primary Completion Date :
    May 1, 2012
    Actual Study Completion Date :
    May 1, 2012

    Arms and Interventions

    Arm Intervention/Treatment
    Extraventricular Drainage

    Includes hydrocephalus patients that are in recovery from shunt explanation.

    Outcome Measures

    Primary Outcome Measures

    1. Volumetric flow of patient cerebrospinal fluid through an Extra-Ventricular Drainage system. [24 hour-period]

    Secondary Outcome Measures

    1. Recording of the pressure waveform related to the volumetric flow of patient cerebrospinal fluid through an Extra-Ventricular Drainage system. [24 hour period]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosed with hydrocephalus

    • Instrumented with an Extraventricular drainage system

    Exclusion Criteria:
    • Not diagnosed with hydrocephalus

    • Not instrumented with an extraventricular drainage system

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 SUNY Upstate Medical University Syracuse New York United States 13210

    Sponsors and Collaborators

    • Transonic Systems Inc.
    • National Institute of Neurological Disorders and Stroke (NINDS)

    Investigators

    • Principal Investigator: Cornelis J Drost, Transonic Systems Inc.
    • Principal Investigator: Satish Krishnamurthy, MD, State University of New York - Upstate Medical University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Transonic Systems Inc.
    ClinicalTrials.gov Identifier:
    NCT01108965
    Other Study ID Numbers:
    • TSI-C-HYDRO-2A-H
    • 5R44NS049680-03
    First Posted:
    Apr 22, 2010
    Last Update Posted:
    May 27, 2016
    Last Verified:
    May 1, 2016
    Keywords provided by Transonic Systems Inc.
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 27, 2016